免疫组化市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测F 按产品、应用、最终用户、地区和竞争情况分类

全球免疫组化市场预计将在预测期内实现令人瞩目的增长。这主要归因于在免疫组化中实施自动化和机器学习的需求不断增长，以及全球各地推出了技术先进的免疫组化解决方案。此外，产品审批的增加和用于疾病诊断的技术先进的 IHC 系统的推出也进一步推动了预测期内市场的增长。同样，制药和生物技术行业研发支出的增长也是推动市场增长的主要因素。此外，对个性化医疗、癌症基因组学研究的日益青睐，以及患者参与度要求的不断提高，预计将在预测期内推动市场需求。同样，在预测期内，抗体在病理学、神经病理学和血液病理学中越来越多的应用预计将进一步提高免疫组化市场的需求。2021 年 8 月，FDA 批准了罗氏公司的 VENTANA MMR RxDx Panel，用于鉴定符合抗 PD-1 免疫疗法条件的 dMMR 实体瘤患者。

慢性病患病率不断上升

癌症发病率的上升以及老年人口的增加是预计将在预测期内进一步推动市场增长的主要因素之一。根据欧盟委员会联合研究委员会 2020 年 7 月发布的报告，预计 2020 年欧盟将诊断出约 270 万例癌症新病例（不包括非黑色素瘤癌症），而乳腺癌将是最常见的癌症形式，2020 年将新增约 35.5 万例病例。此外，慢性肾脏疾病的发病率不断上升，预计将在预测期内带来利润丰厚的增长。此外，通过鉴定酶、肿瘤特异性抗原、肿瘤抑制基因、癌基因和肿瘤细胞增殖标记物来分析肿瘤的需求不断增长，预计将在预测期内提高免疫组化市场的需求。此外，随着心血管疾病、心脏病、哮喘和慢性阻塞性肺部疾病发病率的上升，以及患者到医院就诊人数的增加，也会在预测期内促进免疫组化市场的需求。

个性化医疗需求不断增长

在预测期内，非小细胞肺癌患者对个性化医疗的需求不断增长，从而提高了对免疫组化的需求。此外，这项技术通过对肿瘤进行最完整、最准确的组织学亚型分析，有助于做出适当的治疗决策，从而在未来几年内提高市场需求。同样，在预测期内，能检测 BRAF V600E 和 IDH1 R132H 等突变蛋白的免疫组化检测方法越来越多，这将进一步推动市场的发展。免疫组化可替代或辅助分子检测。这些技术具有高度的可重复性、合理的技术和解释复杂性，而且成本较低。多重和突变特异性免疫组化测定的不断发展是重要的创新，预计将在预测期内进一步推动市场的增长。根据 2020 年 7 月发表在《实验室研究》（Laboratory Investigation）杂志上的研究，免疫组化（IHC）和原位杂交（ISH）测定被用于检测 COVID-19 感染。

最新进展

• 2022 年 6 月，罗氏公司推出 HPV 自采样解决方案，扩大了宫颈癌筛查的选择范围。
• 2022 年 2 月，Moderna 与赛默飞世尔科技公司宣布开展长期战略合作，在美国生产 Spikevax 疫苗，用于诊断 COVID-19 和该管线中其他在研 mRNA 药物。
• 2022 年 2 月，一种新型基因分析仪为桑格测序和片段分析带来了先进功能，即毛细管电泳，它实现了桑格测序和片段分析，这对于改进临床研究和推进科学发现至关重要。

可定制

有了给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。报告可提供以下定制选项：

公司信息

• 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 覆盖市场
  • 研究年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基准方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概述
• 主要市场细分概述
• 主要市场参与者概述
• 主要地区/国家概述
• 市场驱动因素、挑战和趋势概述

第4章：客户之声

第5章：全球免疫组化市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（抗体、设备、试剂、试剂盒）
  • 按应用（诊断、药物检测、法医应用）
  • 按最终用户（医院和诊断实验室、研究所、其他）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司（2022 年）
• 市场地图
  • 按产品
  • 按应用
  • 按最终用户
  • 按地区

第 6 章 : 北美免疫组化市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（抗体、设备、试剂、试剂盒）
  • 按应用（诊断、药物检测、法医应用）
  • 按最终用户（医院和诊断实验室、研究所、其他）
  • 按国家
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章 : 欧洲免疫组化市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（抗体、设备、试剂、试剂盒）
  • 按应用（诊断、药物检测、法医应用）
  • 按最终用户（医院和诊断实验室、研究所、其他）
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章 : 亚太地区免疫组化市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（抗体、设备、试剂、试剂盒）
  • 按应用（诊断、药物检测、法医应用）
  • 按最终用户（医院和诊断实验室、研究所、其他）
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章 : 南美免疫组化市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（抗体、设备、试剂、试剂盒）
  • 按应用（诊断、药物检测、法医应用）
  • 按最终用户（医院和诊断实验室、研究所、其他）
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章 : 中东和非洲免疫组化市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（抗体、设备、试剂、试剂盒）
  • 按应用（诊断、药物检测、法医应用）
  • 按最终用户（医院和诊断实验室、研究所、其他）
  • 按国家
• 中东和非洲：国家分析
  • 南非 免疫组化
  • 沙特阿拉伯 免疫组化
  • 阿联酋 免疫组化

第 11 章 ：市场动态

• 驱动因素
• 挑战

第 12 章 ：市场趋势与发展

• 近期发展
• 合併与收购
• 产品发布

第 13 章 ：全球免疫组化市场：SWOT 分析

第14章：波特五力分析法

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第 15 章 ：竞争格局

• 业务概述
• 产品供应
• 近期发展
• 财务状况（报告）
• 主要人员
• SWOT 分析
  • Thermo Fisher Scientific Inc.
  • F.Hoffmann-La Roche Ltd.
  • Merck KGaA.
  • Danaher Corporation.
  • Perkinelmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology Inc.
  • Bio SB.
  • Agilent Technologies, Inc.
  • Abcam Plc.

第 16 章 ：战略建议

Global Immunohistochemistry market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in immunohistochemistry, along with the introduction of technologically advanced immunohistochemistry solutions across the globe. Moreover, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further driving the growth of the market during the forecast period. Similarly, growing research and development expenditures in the pharmaceutical and biotechnology industries are the major factors driving the growth of the market. Moreover, growing preference for personalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to drive the demand for the market during the forecast period. Similarly, the growing usage of antibodies in pathology, neuropathology, and hematopathology is expected to further enhance the demand for the immunohistochemistry market during the forecast period. In August 2021, the FDA approved Roche's VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy.

Growing Prevalence of Chronic Diseases

The growing prevalence of cancer, along with the increasing geriatric population, is one of the major factors which is expected to further boost the growth of the market during the forecast period. As per the Joint Research Commission's report European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. Moreover, the growing prevalence of chronic kidney disorders is expected to create lucrative growth during the forecast period. Furthermore, growing demand for analyzing tumors by identification of enzymes, tumor-specific antigens, tumor suppressor genes, oncogenes, and tumor cell proliferation markers is expected to enhance demand for the immunohistochemistry market during the forecast period. Moreover, the growing incidence of cardiovascular diseases, heart diseases, asthma, and chronic obstructive pulmonary diseases, along with the rising number of patient visits to hospitals, can enhance the demand for the immunohistochemistry market during the forecast period.

Growing Demand for Personalized Medicine

The growing demand for personalized medicine for non-small cell lung cancer patients enhanced the demand for immunohistochemistry during the forecast period. Moreover, this technique helps in making appropriate treatment decisions by performing the most complete and accurate histological subtyping of tumors possible, which can enhance the demand for the market over the years. Similarly, the growing availability of immunohistochemistry assays that can detect mutant proteins such as BRAF V600E and IDH1 R132H will further drive the market during the forecast period. It can provide a helpful replacement or adjunct for molecular testing. These techniques are highly reproducible, entail reasonable technical and interpretation complexity, and are also available at lesser costs. The growing development of multiplex and mutation-specific immunohistochemistry assays represents important innovations that are expected to further drive the growth of the market during the forecast period. According to research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting COVID-19 infection.

Market Segmentation

Global Immunohistochemistry market can be segmented on the basis of product, application, end-user, and by region. Based on the product, the market can be segmented into antibodies, equipment, reagents, and kits. On the basis of application, the market can be segmented into diagnostics, drug testing, and forensic applications. Based on end-user, the market can be further divided into hospitals & diagnostic laboratories, research institutes, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global immunohistochemistry market on account of the growing prevalence of chronic diseases in the country.

Recent Developments

• In June 2022, Roche launched HPV self-sampling solution and expanded cervical cancer screening options.
• In February 2022, Moderna and Thermo Fisher Scientific announced a long-term strategic collaboration for manufacturing of Spikevax vaccine in the U.S. for diagnosis of COVID-19 and other investigational mRNA medicines in this pipeline.
• In February 2022, a new genetic analyzer brought advanced capabilities to sanger sequencing and fragment analysis, which is called capillary electrophoresis, and it enables sanger sequencing and fragment analysis, which is essential for improving clinical research and advancing scientific discovery.

Market Players

Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc. are some of the leading players operating in the global Immunohistochemistry market.

Report Scope

In this report, global Immunohistochemistry market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Immunohistochemistry Market, By Product:

• Antibodies
• Equipment
• Reagents
• Kits

Immunohistochemistry Market, By Application:

• Diagnostics
• Drug Testing
• Forensic applications

Immunohistochemistry Market, By End User:

• Hospitals & Diagnostic Laboratories
• Research Institutes
• Others

Immunohistochemistry Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunohistochemistry Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunohistochemistry Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
  • 5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
  • 5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Product
  • 5.3.2 By Application
  • 5.3.3 By End User
  • 5.3.4 By Region

6. North America Immunohistochemistry Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
  • 6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
  • 6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Immunohistochemistry Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Immunohistochemistry Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Immunohistochemistry Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Immunohistochemistry Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
  • 7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
  • 7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Immunohistochemistry Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Immunohistochemistry Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Immunohistochemistry Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Immunohistochemistry Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Immunohistochemistry Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Immunohistochemistry Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
  • 8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
  • 8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Immunohistochemistry Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Immunohistochemistry Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Immunohistochemistry Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Immunohistochemistry Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Immunohistochemistry Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Immunohistochemistry Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
  • 9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
  • 9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Immunohistochemistry Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Immunohistochemistry Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Immunohistochemistry Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Immunohistochemistry Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
  • 10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
  • 10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Immunohistochemistry Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Immunohistochemistry Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Immunohistochemistry Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Immunohistochemistry Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Thermo Fisher Scientific Inc.
  • 15.6.2 F.Hoffmann-La Roche Ltd.
  • 15.6.3 Merck KGaA.
  • 15.6.4 Danaher Corporation.
  • 15.6.5 Perkinelmer, Inc.
  • 15.6.6 Bio-Rad Laboratories, Inc.
  • 15.6.7 Cell Signaling Technology Inc.
  • 15.6.8 Bio SB.
  • 15.6.9 Agilent Technologies, Inc.
  • 15.6.10 Abcam Plc.

16. Strategic Recommendations